Walking Helps Leukemia Chemotherapy Patients

A study published in the May issue of the Journal of Pain and Symptom Management  indicates that a walking exercise program can  reduce fatigue levels in those AML( acute myelogenous leukemia) patients  who are being treated with chemotherapy.

Dr. Yeur-Hur Lai of National Taiwan University in Taipei and colleagues randomly assigned 22 hospitalized AML patients  to either a walking group or a control group receiving standard ward care.  The walking group walked 12 minutes each day for 5 days a week for a period of 3 weeks.  All patients were evaluated before chemotherapy and on day 7,14 and 21 of the chemotherapy.

The investigation found that those in the walking had lower levels of fatigue intensity and interference than the control.   They also found that symptom distress, anxiety and depression were lower in the walking group.

"Taken together, our preliminary findings suggest that a brief exercise-driven program, such as the walking exercise program, should be started at the beginning of chemotherapy to decrease chemotherapy-related fatigue," Lai's team concluded. "Standardizing the walking exercise program as part of a chemotherapy-related care model should be feasible and encouraged to improve cancer-related fatigue experiences."

Another example AML-Benzene case

This one is also from the Texas area.  This shows a typical situation where the AML was possibly caused by benzene exposure.  We see independent contractors as clients fairly often, because this is how a lot of work was done at these refineries.

An independent contractor for various local refineries during the '60s and early '70s, John Thompson says he was negligently exposed to benzene - a chemical which he claims has caused him to develop leukemia.

John and his wife Carol Thompson have filed suit against Chevron U.S.A. and eight other chemical companies on Feb. 7 in the Jefferson County District Court.

Some of the other defendants named in the suit include Texaco, E.I. DuPont, ExxonMobil and Goodrich.

According to the plaintiffs' petition, "at various times over a (decade) John Thompson was employed by various independent contractor employers as a laborer … upon the premises of the Defendants, (where he) was occupationally exposed to various toxic and carcinogenic chemicals benzene."

As a result of his benzene exposure, Thompson claims he developed acute myelogenous leukemia, the suit said.

Source: Southeast Texas Record

AML Benzene case filed in Illinois

Why would it be important to list how a person learned about the connection between AML and benzene? 

This article, I found,  lists that as the headline.  The person who filed the lawsuit learned about the connection between AML and Benzene from a TV ad.  The reason it may be important is that the case may have a problem with the statute of limitations

The Statute of Limitations is a law which limits the amount of time that you have to file a lawsuit.  In some states it can be very short (1 year) and in others it can be 3 years or more.  In a lot of the states, the law is written in such a way that the statute of limitations "clock" doesn't start until after you learn of the connection between the disease and benzene. 

This is called the discovery rule.  The time starts to run you discover the connection between your injury and the benzene.  This is not true in all states, so you have to carefully read the law to find out.

Here's the article:  "TV Ad informs laborer of links to disease"

Had it not been for a television advertisement, laborer Steve Ivkovcic may not have known the reason he developed acute myelogenous leukemia was because of benzene-containing products he was exposed to at work.

Ivkovcic, a machinist and tool and die maker, filed a benzene suit against 11 defendant corporations in Madison County Circuit Court Feb. 7, alleging benzene caused his disease.

"Steve Ivkovcic did not know that the products (he was exposed to at work) contained benzene, or that benzene could cause Acute Myelogenous Leukemia until approximately August of 2007 when he saw a television advertisement," the complaint states.

Ivkovcic was employed at Pactiv in Wheeling, Ill. from 1986 until 2007, and at Johnson Motors in Waukegan, Ill. from 1970 until 1986.

He claims that during his employment at Johnson Motors, he was exposed to benzene and benzene-containing products which were manufactured and/or sold by the defendants, which include BP Products North America Inc., BP Corporation North America Inc., BP Amoco Chemical Company, Exxon Corporation, Exxon Mobil Corporation, Exxon Mobil Oil, Radiator Specialty Company, Sunoco, Inc., Sunoco (R&M), United States Steel and Aristech Chemical.

Ivkovcic claims the benzene-containing products consisted of products known as "Naptha" which was manufactured by Amoco and Mobil.

According to the complaint, Naptha was manufactured at Amoco at its Wood River refinery.

He was diagnosed with AML in the summer of 2006, the complaint states.

AML is a fast-growing cancer of the blood and bone marrow - the spongy tissue inside bones where blood cells are made.

Ivkovcic claims the defendants were negligent by failing to use ordinary care to eliminate benzene from products and failed to provide a safe place for him to work.

He also claims the defendants failed to give adequate warnings of the harmful effects associated with exposure to benzene and benzene-containing products and failed to provide adequate safety equipment and/or failed to recommend adequate safety and control measures.

According to Ivkovcic, his disease has disabled and disfigured him, caused him to incur medical expenses, and has caused great physical pain and mental anguish.

Represented by Thomas Schwartz of Holloran, White & Schwartz in St. Louis and L. Jeth Jones of Houston, Ivkovcic is seeking damages in excess of $150,000, plus costs of the suit.

The case has been assigned to Circuit Judge Nicholas Byron.

Source:  St.Clair Record

What is AML- Acute Myelogenous Leukemia

Acute myelogenous leukemia (AML) is a blood disease of your blood. AML is when you do not have enough red and white blood cells.  Another way to describe AML is that your blood grows Blasts which are a early type of white blood cell.  It grows these blasts so fast that they basically push out all of the other white  and red blood cells.  If you have AML Leukemia you will not have enough red blood cells and not enough white blood cells because they are outnumbered.

AML is often a result of exposure to some sort of environmental toxin, such as benzene or radiation

Other names that you might hear for AML are Acute myeloblastic leukemia, acute myelocytic leukemia and acute nonlymphocytic leukemia.

AML Symptoms

Just a quick post listing some of the common symptoms related to Acute Myelogenous Luekemia

  • Shortness of Breath
  • Fatigue (Feeling Sleepy or Tired)
  • Bruise easily
  • Cuts heal very slowly or you bleed easily
  • Repeated infections
  • Joint Pain
  • Mild fevers
Don't give yourself a diagnosis of AML based on this list.  Go see your doctor and discuss it with him or her.